Active ingredients: paclitaxel
What it is used for
Primary treatment of ovarian cancer in combination with a platinum agent. Treatment of metastatic ovarian cancer and breast cancer, after failure of standard therapy. Treatment of non-small cell lung cancer (NSCLC). Adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin), in patients who have tumours that overexpress HER-2 and who have not received previous chemotherapy for their previous metastatic disease.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store below 25 degrees Celsius
- Protect from Light
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
clear concentrated solution for infusion
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient paclitaxel
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.